Key Market Indicators
Sales of Swiss Blood and Blood Forming Organs Medicine are expected to reach $540.7 million by 2026. This is a 2.6% increase compared to 2021's sales of $457.2 million. Since 1992, the Swiss market has grown at an average rate of 7.1% year-on-year. In 2021, Switzerland held the 12th spot in the ranking, with Sweden overtaking them with sales of $457.2 million. Germany, Italy and South Korea respectively ranked 2nd, 3rd and 4th. Swiss Anemia Prevalence is forecast to reach 3,810 Hospital Discharges by 2026, a 0.2% year-on-year growth from 2021's 3,770 Hospital Discharges. Since 2007, demand in Switzerland has increased 1.1% year-on-year. In 2021, the country ranked 26th, with Norway coming in ahead with 3,770 Hospital Discharges. Germany, the United Kingdom and Poland respectively ranked 2nd, 3rd and 4th.
